Metraipolis › archive › dc_c7cc2fb4c4fc

Efficacy and safety of esaxerenone with and without sodium-glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a… — Europe PMC PMID:40890417

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40890417
DOI
10.1038/s41440-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-10T05:59:32.285Z
SHA-256 of the archived text
a50453038f3dadbb4d2b7b520913f513714164bebf8f5a08af46dd0113f2db69
Stable URL of this page
https://metraipolis.com/documento/dc_c7cc2fb4c4fc

How to cite

Efficacy and safety of esaxerenone with and without sodium-glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a… — Europe PMC PMID:40890417 — Europe PMC (en), https://europepmc.org/article/MED/40890417 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7cc2fb4c4fc (Metraipolis archive dc_c7cc2fb4c4fc, sha256 a50453038f3dadbb4d2b7b520913f513714164bebf8f5a08af46dd0113f2db69)
BibTeX
@misc{dcc7cc2fb4c4fc,
  title = {Efficacy and safety of esaxerenone with and without sodium-glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a… — Europe PMC PMID:40890417},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40890417},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7cc2fb4c4fc; sha256 a50453038f3dadbb4d2b7b520913f513714164bebf8f5a08af46dd0113f2db69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40890417. Agents can read the archived copy with the MCP tool read_document.